Parkinson's is not classified as an autoimmune disease, but the immune system does play a role in how it develops
Parkinson's disease damages the neurons that produce dopamine, a chemical your brain uses to control movement. In autoimmune diseases like rheumatoid arthritis or lupus, the immune system mistakenly attacks the body's own cells. In Parkinson's, the immune system is not the primary driver of cell death — instead, proteins misfold and accumulate inside neurons, and those damaged cells die. However, research over the past decade has found that immune cells do become active in the brains of people with Parkinson's, which suggests the immune system may contribute to the disease's progression even if it is not the root cause.
This distinction matters because it shapes how doctors treat the disease and how researchers look for new treatments. If Parkinson's were primarily autoimmune, immunosuppressant drugs might slow it down. Since it is not, current treatments focus on replacing dopamine or protecting the neurons that remain.
Key Takeaways
- Parkinson's is caused by the death of dopamine-producing neurons, not by the immune system attacking those cells.
- Immune cells do become active in Parkinson's brains, but they appear to be responding to damage rather than causing it.
- The misfolding of a protein called alpha-synuclein is the hallmark of Parkinson's, and this process is not autoimmune in nature.
- Some people with Parkinson's also have other autoimmune conditions, but the two diseases develop through different mechanisms.
How Parkinson's damages the brain differently from autoimmune diseases
In autoimmune diseases, the immune system produces antibodies or activates T cells that directly attack specific tissues. In rheumatoid arthritis, for example, immune cells attack the joints. In Parkinson's, no such antibodies or targeted immune attack has been found. Instead, neurons die because a protein called alpha-synuclein misfolds and clumps together inside the cell, forming structures called Lewy bodies. These clumps interfere with the cell's ability to function and eventually kill it.
This protein misfolding appears to spread from cell to cell over time, which is why Parkinson's symptoms worsen gradually. The immune system does not cause this misfolding — it appears to be triggered by a combination of genetics, aging, and environmental factors that scientists are still working to understand.
Why immune cells are active in Parkinson's brains
Brain imaging and tissue studies have shown that immune cells called microglia become activated in the brains of people with Parkinson's. Microglia are the immune cells that live in the brain and normally clean up debris and dead cells. In Parkinson's, these cells become overactive, and some researchers believe this overactivity may speed up the death of dopamine neurons or prevent the brain from clearing away the toxic protein clumps.
However, set up of microglia is not the same as autoimmune attack. The microglia are responding to damage that is already happening, not causing the damage itself. Think of it like firefighters arriving at a burning building — their presence at the scene does not mean they started the fire, but their response to the fire matters for what happens next.
This is why some researchers are exploring whether drugs that calm down microglial set up might slow Parkinson's progression. These drugs would not treat an autoimmune disease; they would reduce a harmful side effect of the brain's response to protein damage.
The role of genetics and environment in Parkinson's
Parkinson's develops when a person's genes and their environment interact over time. Some people inherit mutations in genes like LRRK2 or GBA that make them more likely to develop Parkinson's. Others develop the disease without any known genetic mutation, possibly because of exposure to pesticides, head injury, or other environmental factors. In both cases, the disease mechanism is the same: alpha-synuclein misfolds and accumulates.
Autoimmune diseases, by contrast, often run in families and are triggered by specific infections or exposures that set up the immune system against the body's own tissues. Parkinson's does not follow this pattern. While some people with Parkinson's also have autoimmune conditions like celiac disease or thyroid disease, these are separate conditions that happen to occur in the same person, not different expressions of the same disease.
What happens if someone has both Parkinson's and an autoimmune condition
Some people develop both Parkinson's and an autoimmune disease such as rheumatoid arthritis or Hashimoto's thyroiditis. When this happens, the two diseases are treated separately because they have different causes and require different approaches. The autoimmune condition may be treated with immunosuppressants, while Parkinson's is treated with dopamine-replacement drugs or other neuroprotective strategies.
Having an autoimmune condition does not cause Parkinson's, and having Parkinson's does not cause autoimmune disease. The overlap appears to be coincidental, though some researchers are investigating whether shared genetic factors might make certain people more vulnerable to both.
Current research into immune involvement in Parkinson's
Scientists are actively studying how the immune system contributes to Parkinson's progression, even though the disease is not autoimmune. Studies are looking at whether certain infections might trigger alpha-synuclein misfolding, whether the gut microbiome influences immune set up in the brain, and whether blocking specific immune pathways might slow neuronal death.
Some of this research has led to clinical trials of drugs that were originally developed for autoimmune diseases, but they are being tested in Parkinson's for a different reason — to see if reducing inflammation in the brain helps protect dopamine neurons. These trials are still ongoing, and results so far have been mixed.
Why the distinction between autoimmune and non-autoimmune matters for treatment
If Parkinson's were autoimmune, doctors would use immunosuppressant drugs as a first-line treatment, the way they do for lupus or multiple sclerosis. Instead, the standard treatments for Parkinson's are levodopa (which the brain converts to dopamine) and other drugs that either mimic dopamine or prevent its breakdown. These drugs do not address the underlying cause of neuronal death, but they restore enough dopamine to reduce tremor, stiffness, and slowness of movement.
The fact that Parkinson's is not autoimmune also means that immunosuppressants are not routinely prescribed for it. However, if future research shows that immune set up significantly speeds progression, drugs that calm the immune response might become part of the treatment toolkit — not as a cure, but as a way to slow the disease's advance.
Frequently Asked Questions
Can you catch Parkinson's from someone else?
No. Parkinson's is not contagious and is not caused by an infection. It develops over time due to the misfolding of proteins in your own brain cells. You cannot catch it from another person, and having Parkinson's does not put others at risk.
If I have an autoimmune disease, am I more likely to develop Parkinson's?
Having an autoimmune condition does not increase your risk of developing Parkinson's. The two diseases develop through different mechanisms. Some people happen to have both, but this appears to be coincidence rather than a causal link.
Will immunosuppressant drugs help slow Parkinson's?
Standard immunosuppressants are not used to treat Parkinson's because the disease is not autoimmune. However, researchers are testing whether drugs that reduce brain inflammation might help protect dopamine neurons. These trials are still underway, and it is too early to know whether they will be effective.
Does stress or infection trigger Parkinson's?
Stress and infection do not directly cause Parkinson's, but some research suggests that infections or other triggers might accelerate the misfolding of alpha-synuclein in people who are already genetically vulnerable. This is still an active area of research.
Is Parkinson's hereditary?
Some forms of Parkinson's are hereditary — mutations in genes like LRRK2 or GBA significantly increase risk. However, most people with Parkinson's do not have a family history, meaning their disease was likely triggered by a combination of aging and environmental factors rather than inherited genes.